| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Humacyte, Inc. (HUMA) has 4 insiders with recent SEC Form 4 filings, including 8 buys and 2 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 318.6K | $294.5K | - | |
| CFO | 313.1K | $289.4K | - | |
| CEO | 311.1K | $287.6K | - | |
| Dir | 311.1K | $287.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 15, 2022 | Dougan Brady W64 | Director, 10% Owner | Sell | 1,522,500 | $4.00 | $6,090,000.00 | -7.4% | -32.5% | -20.9% | |
| Sep 15, 2022 | Ayabudge LLC | 10% Owner | Sell | 1,522,500 | $4.00 | $6,090,000.00 | -7.4% | -32.5% | -20.9% | |
| Sep 15, 2022 | Niklason Laura E65 | President, CEO And Director | Buy | 2,000 | $4.14 | $8,280.00 | +0.2% | -32.5% | -20.9% | |
| Sep 15, 2022 | Dougan Brady W64 | Director, 10% Owner | Buy | 2,000 | $4.14 | $8,280.00 | +0.2% | -32.5% | -20.9% | |
| Sep 2, 2022 | Binder Gordon M | Director | Buy | 61,841 | $4.40 | $272,100.40 | +128.4% | -28.0% | -7.3% | |
| Sep 1, 2022 | Binder Gordon M | Director | Buy | 48,159 | $4.00 | $192,636.00 | New | -25.4% | -3.3% | |
| May 24, 2022 | Scheessele William John | Chief Commercial Officer | Buy | 10,525 | $4.72 | $49,678.00 | New | -11.3% | -17.6% | |
| May 23, 2022 | Niklason Laura E65 | President, CEO And Director | Buy | 10,000 | $4.83 | $48,300.00 | +0.9% | -11.2% | -15.4% | |
| May 23, 2022 | Dougan Brady W64 | Director, 10% Owner | Buy | 10,000 | $4.83 | $48,300.00 | +0.9% | -11.2% | -15.4% | |
| May 23, 2022 | Constantino Michael T. | Director | Buy | 2,000 | $4.83 | $9,660.00 | +80.0% | -11.2% | -15.4% |